Open-Label Surufatinib in European Patients With NET
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Schelman, MD, PhD
Hutchmed
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chu Bordeaux
Pessac, France
- Institut Gustave Roussy
Villejuif, France
- Charite Universitatsmedizin Berlin
Berlin, Germany
- Universitaetsklinikum Erlangen
Erlangen, Germany
- Universitatsklinikum Essen, Klinik Fur Endokrinologie
Essen, Germany
- Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari
Bari, Italy
- Asst-Spedali Civili Di Brescia
Brescia, Italy
- Universita Degli Studi Di Firenze - Azienda Ospedaliero Universitaria Careggi (aouc)
Florence, Italy
- Istituto Europeo Di Oncologia
Milan, Italy
- Haukeland University Hospital
Bergen, Norway
- Oslo University Hospital Rikshospitalet
Oslo, Norway
- Hospital Vall Hebron
Barcelona, Spain
- Institut Catala D'Oncologis (ico) - Hospital Duran I Reynals
Barcelona, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Universitario Ramon Y Cajal
Madrid, Spain
- Hospital Universitario Virgen del Rocio
Seville, Spain
- Sarah Cannon Research Institute
London, United Kingdom
- Christie Hospital
Manchester, United Kingdom
- University of Alabama, Birmingham (uab)
Birmingham, Alabama, United States
- University of California Irvine Medical Center Ucimc - H.H. Chao Comprehensive Digestive Disease Center Cddc
Orange, California, United States
- Emory University, Winship Cancer Institute
Atlanta, Georgia, United States
- Stony Brook Cancer Center
Stony Brook, New York, United States
- Houston Methodist
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Aug 2021
- Primary completion
- 6 Sept 2024
- Completion
- 15 Oct 2024
- Last update posted
- 25 Jul 2025
- Registered enrollment
- 78
- Registry id
- NCT04579679
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.